Clal Biotechnology Industries

Tel Aviv, Israel Founded: 1993 • Age: 33 yrs
Life Sciences focused VC firm investing in Israel and the US
Annual revenue $118,741 Latest available
Total funding - 1 rounds
Employees 111 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Clal Biotechnology Industries

Clal Biotechnology Industries is a company based in Tel Aviv (Israel) founded in 1993. The company has 111 employees as of December 31, 2024.

  • Headquarter Tel Aviv, Israel
  • Employees 111 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Financial Services
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Clal Biotechnology Industries Ltd
Operational Areas
Financial Services → Private Capital & Alternative Investments Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $118.74 K (USD)
    -27.23
    as on Dec 31, 2024
  • Net Profit
    -$17.13 M (USD)
    -101.14
    as on Dec 31, 2024
  • EBITDA
    -$13.9 M (USD)
    -10.01
    as on Dec 31, 2024
  • Latest Funding Round
    $2 M (USD), Post-IPO

    Aug 01, 2012

  • Investors
    Not available
  • Employee Count
    111

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Clal Biotechnology Industries

Clal Biotechnology Industries is a publicly listed company on the TASE with ticker symbol CBI in Israel, operating in the Finance sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: TASE · Ticker: CBI · Sector: Finance · Israel

Funding Insights of Clal Biotechnology Industries

Investments & Acquisitions by Clal Biotechnology Industries

Investments
Premium access

Investment portfolio details for Clal Biotechnology Industries

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Clal Biotechnology Industries

Premium access

Detailed financials for Clal Biotechnology Industries

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Clal Biotechnology Industries Comparisons

Clal Biotechnology Industries Primary company
Description
Life Sciences focused VC firm investing in Israel and the US
Location
Tel Aviv, Israel
Founded Year
1993
Annual Revenue
$118.74 K (USD)
Net Profit
-$17.13 M (USD)
EBITDA
-$13.9 M (USD)
Employees
111
As of 2024
Premium access

Peer comparison for Clal Biotechnology Industries

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Clal Biotechnology Industries

Premium access

Detailed competitors of Clal Biotechnology Industries

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Clal Biotechnology Industries

MediWound Announces CEO Transition
Reuters4 years ago
Premium access

Complete news archive for Clal Biotechnology Industries

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Clal Biotechnology Industries

Clal Biotechnology Industries was founded in 1993 and raised its 1st funding round 19 years after it was founded.

Clal Biotechnology Industries is headquartered in Tel Aviv, Israel.

Avi Fischer is the current CEO of Clal Biotechnology Industries.

As of Dec 31, 2024, the latest employee count at Clal Biotechnology Industries is 111.

Annual revenue of Clal Biotechnology Industries is $118.74K as on Dec 31, 2024.

Clal Biotechnology Industries(CBI) is a venture capital firm that makes investments in Israel and the US. The firm invests in Life Sciences companies operating in sectors such as Biotechnology and Medical Devices. Top portfolio companies are Biokine, Cure Tech, BioCancell, Cologuard, etc.

Yes, Clal Biotechnology Industries is publicly traded on TASE under the ticker symbol CBI.

The ticker symbol of Clal Biotechnology Industries is CBI on TASE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available